@article{0115ef6ed90a4712b262f93b1616aac4,
title = "Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment",
keywords = "bispecific antibody, coagulation, hemophilia-a, BISPECIFIC ANTIBODY, HEMOPHILIA-A, COAGULATION",
author = "L.L.F.G. Valke and E.A.M. Beckers and N.M.A. Blijlevens and \{van Heerde\}, W.L. and S.E.M. Schols",
note = "Funding Information: WLvH has no conflict of interest regarding this study. WLvH received unrestricted grants from Bayer, Shire, Novo Nordisk an CSL Behring. WLvH is the founder and CSO of Enzyre BV, a Radboudumc spinoff company. LLFGV, EAMB, NMAB and SEMS have no conflict of interests to declare.",
year = "2020",
month = nov,
day = "1",
doi = "10.1111/hae.14085",
language = "English",
volume = "26",
pages = "E327--E330",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "John Wiley \& Sons Inc.",
number = "6",
}